To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Non-Graft-versus-Host Dis… - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Non-Graft-versus-Host Disease Ocular Complications after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation

Journal article
Authors Y. Inamoto
I. Petricek
L. Burns
S. Chhabra
Z. DeFilipp
P. Hematti
A. Rovo
R. Schears
A. Shah
V. Agrawal
A. Ahmed
I. Ahmed
A. Ali
M. Aljurf
H. Alkhateeb
A. Beitinjaneh
N. Bhatt
D. Buchbinder
M. Byrne
N. Callander
Kristina Teär Fahnehjelm
N. Farhadfar
R. P. Gale
S. Ganguly
S. Hashmi
G. C. Hildebrandt
E. Horn
A. Jakubowski
R. T. Kamble
J. Law
C. Lee
S. Nathan
O. Penack
R. Pingali
P. Prasad
D. Pulanic
S. Rotz
A. Shreenivas
A. Steinberg
K. Tabbara
A. Tichelli
B. Wirk
J. Yared
G. W. Basak
M. Battiwalla
R. Duarte
B. N. Savani
M. E. D. Flowers
B. E. Shaw
N. Valdes-Sanz
Published in Biology of Blood and Marrow Transplantation
Volume 25
Issue 5
Pages E145-E154
ISSN 1083-8791
Publication year 2019
Published at Institute of Neuroscience and Physiology, Department of Clinical Neuroscience
Pages E145-E154
Language en
Links dx.doi.org/10.1016/j.bbmt.2018.11.0...
Keywords Hematopoietic cell, transplantation, Complication, Eye, Review, Prevention, Treatment, nervous-system lymphoma, term-follow-up, cytomegalovirus retinitis, risk-factors, randomized-trial, macular edema, retinal, microvasculopathy, intraocular-pressure, adenovirus infection, toxoplasma-gondii, Hematology, Immunology, Transplantation
Subject categories Neurosciences, Hematology

Abstract

Non-graft-versus-host disease (GVHD) ocular complications are generally uncommon after hematopoietic cell transplantation (HCT) but can cause prolonged morbidity affecting activities of daily living and quality of life. Here we provide an expert review of non-GVHD ocular complications in a collaboration between transplantation physicians and ophthalmologists through the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation. Complications discussed in this review include cataracts, glaucoma, ocular infections, ocular involvement with malignancy, ischemic microvascular retinopathy, central retinal vein occlusion, retinal hemorrhage, retinal detachment and ocular toxicities associated with medications. We summarize the incidence, risk factors, screening, prevention, and treatment of individual complications and generate evidence-based recommendations. Baseline ocular evaluation before HCT should be considered in all patients who undergo HCT. Follow-up evaluations should be considered according to clinical signs and symptoms and risk factors. Better preventive strategies and treatments remain to be investigated for individual ocular complications after HCT. Both transplantation physicians and ophthalmologists should be knowledgeable about nonGVHD ocular complications and provide comprehensive collaborative team care. (C) 2018 American Society for Blood and Marrow Transplantation.

Page Manager: Webmaster|Last update: 9/11/2012
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?